Shilpak Chatterjee

S.P. Mukherjee Road
Kolkata, WB 700026, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Interplay between membrane protrusive activities and their adhesion strength regulates cell migration.

Interplay between membrane protrusive activities and their adhesion strength regulates cell migration.

Journal: Molecular biology of the cell

Published: March 25, 2026

Burden of MASLD and liver fibrosis: evidence from Phenome India cohort.

Burden of MASLD and liver fibrosis: evidence from Phenome India cohort.

Journal: The Lancet regional health. Southeast Asia

Published: October 14, 2025

Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

Journal: Nature communications

Published: September 22, 2025

S1P-S1PR1 signaling impairs CD8+ T cell metabolism and effector function in tumors.

S1P-S1PR1 signaling impairs CD8+ T cell metabolism and effector function in tumors.

Journal: EMBO reports

Published: July 07, 2025

The hypoxia-induced chromatin reader ZMYND8 drives HIF-dependent metabolic rewiring in breast cancer.

The hypoxia-induced chromatin reader ZMYND8 drives HIF-dependent metabolic rewiring in breast cancer.

Journal: The Journal of biological chemistry

Published: June 13, 2025

CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor.

CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor.

Journal: Science advances

Published: March 21, 2025

CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer.

CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 07, 2024

Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer.

Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer.

Journal: Cells

Published: March 10, 2023

Editorial: Signaling pathways behind immune evasion and therapy resistance.

Editorial: Signaling pathways behind immune evasion and therapy resistance.

Journal: Frontiers in immunology

Published: November 21, 2022

Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19.

Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19.

Journal: Gut pathogens

Published: November 21, 2022

Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19.

Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19.

Journal: Viruses

Published: November 01, 2022

Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.

Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.

Journal: Mayo Clinic proceedings. Innovations, quality & outcomes

Published: September 19, 2022

Showing 1-12 of 41

Last Updated: 09/26/2026